Markets:

Overview

News

Currencies

International

Treasuries

Laboratory Corp American Holdings (NY:LH)

265.83 -0.83 (-0.31%)

Streaming Delayed Price Updated: 12:15 PM EST, Jan 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

How to Buy Stocks in a Recession ↗

May 16, 2022

The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward.

Via InvestorPlace

Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing

May 16, 2022

From Labcorp

Via Business Wire

Labcorp Acquires Diagnostic Clinical Laboratory Services From AtlantiCare

May 09, 2022

From Labcorp

Via Business Wire

Laboratory Corp: Q1 Earnings Insights ↗

April 28, 2022

Laboratory Corp (NYSE:LH) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Via Benzinga

Expert Ratings for Laboratory Corp ↗

April 25, 2022

Within the last quarter, Laboratory Corp (NYSE:LH) has observed the following analyst ratings:

Via Benzinga

7 Oversold Stocks That Shouldn’t Be. Buy Them Now. ↗

May 06, 2022

Consider these seven oversold stocks, as fear, uncertainty and doubt have knocked them down to too low a price.

Via InvestorPlace

Labcorp to Webcast Its Annual Meeting of Shareholders

May 04, 2022

From Labcorp

Via Business Wire

Labcorp Announces 2022 First Quarter Results

April 28, 2022

From Labcorp

Via Business Wire

Labcorp Launches Convenient Home Diagnostic Test Collection Service in Collaboration With Getlabs

April 22, 2022

From Labcorp

Via Business Wire

Earnings Scheduled For February 10, 2022 ↗

February 10, 2022

Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.

Via Benzinga

What 5 Analyst Ratings Have To Say About Laboratory Corp ↗

January 28, 2022

Analysts have provided the following ratings for Laboratory Corp (NYSE:LH) within the last quarter:

Via Benzinga

Labcorp Enhances Cell and Gene Therapy Development Support Through Collaboration With Xcell Biosciences

April 19, 2022

From Labcorp

Via Business Wire

Laboratory Corporation of America Holdings (NYSE:LH) Investor Notice: Investigation over Potential Wrongdoing ↗

April 13, 2022

San Diego, CA -- (SBWIRE) -- 04/13/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Laboratory Corporation of America Holdings.

Via SBWire

Labcorp Initiates Quarterly Dividend

April 07, 2022

From Labcorp

Via Business Wire

Labcorp to Announce First Quarter Financial Results on April 28, 2022

March 28, 2022

From Labcorp

Via Business Wire

New Labcorp Offering Makes Detecting, Measuring Unintentional Gluten Consumption Simple and Effective

March 17, 2022

From Labcorp

Via Business Wire

Labcorp Completes Acquisition of Personal Genome Diagnostics

February 21, 2022

From Labcorp

Via Business Wire

Expert Ratings For Laboratory Corp ↗

February 14, 2022

Over the past 3 months, 6 analysts have published their opinion on Laboratory Corp (NYSE:LH) stock. These analysts are typically employed by large Wall Street banks and tasked...

Via Benzinga

Labcorp's Q4 Earnings Beat Consensus Despite 15% Decline In COVID-19 Testing Sales ↗

February 10, 2022

Laboratory Corp of America Holdings (NYSE: LH)

Via Benzinga

Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market

February 16, 2022

Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years....

Via FinancialNewsMedia

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Laboratory Corp: Q4 Earnings Insights ↗

February 10, 2022

Laboratory Corp (NYSE:LH) reported its Q4 earnings results on Thursday, February 10, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Via Benzinga

Labcorp Announces 2021 Fourth Quarter and Full-Year Results

February 10, 2022

From Labcorp

Via Business Wire

Labcorp Enters Comprehensive, Long-Term Laboratory Relationship With Ascension

February 09, 2022

From Labcorp

Via Business Wire

Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest

February 07, 2022

From Labcorp

Via Business Wire

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Labcorp Launches Labcorp OnDemand Digital Health Platform

February 04, 2022

From Labcorp

Via Business Wire

Labcorp Named to Fortune® Magazine’s 2022 ‘World’s Most Admired Companies’ List for the Fourth Time

February 02, 2022

From Labcorp

Via Business Wire

Laboratory Corporation of America Holdings (NYSE:LH) Investor Notice: Investigation over Possible Violations of Securities Laws ↗

January 31, 2022

San Diego, CA -- (SBWIRE) -- 01/31/2022 -- Laboratory Corporation of America Holdings is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

Abbott Labs Outlook Cools the Omicron Led Testing Boom ↗

January 28, 2022

Photo by Adam Nieścioruk on Unsplash

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.